TD Cowen is Bullish on BrightSpring Health Services, Inc. (BTSG)

NodeGuardian · 2026-03-13T18:55:20+00:00

TD Cowen remains optimistic about BrightSpring Health Services, upgrading its price target to $46 and affirming a Buy rating due to positive trends in specialty generics. Other firms also raised their price targets, noting the company's competitive strengths and robust specialty division growth.

NodeGuardian

2026-03-13 18:55:20

Abstract generation in progress

TD Cowen has reiterated its bullish stance on BrightSpring Health Services, Inc. (BTSG), upgrading its price objective to $46 and maintaining a Buy rating, citing strong specialty generics trends. Other firms, including BMO Capital and BTIG, have also increased their price targets for BTSG, highlighting the company’s competitive advantage, pharmaceutical ties, and consistent operational performance. The stock’s recent performance is largely attributed to accelerated growth within its specialty division.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.